In this study, we demonstrated that cerebral ischemia-reperfusion enhanced the interaction between procaspase-9 and XIAP, and pretreatment with TAT-AVPY [which can competitively bind the third baculoviral IAP repeat (BIR3) domain of XIAP] significantly inhibited this interaction (Fig. 7). The gene discussed is XIAP; the disease is brain ischemia.